A Win For InflaRx N.V.
Mon, Mar 02, 2020 at 05:30 PM
InflaRx N.V. (IFRX:NASDAQ) rocketted at $6.08, representing a gain of 43.4%. The stock got featured on our News Catalysts scanner on Wed 26 Feb 20 at 05:14 PM in the 'BIOTECH' category. From Fri 07 Feb 20, the stock recorded 35.71% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About InflaRx N.V. (IFRX:NASDAQ)
InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.
Top 10 Gainers:
- Heat Biologics, Inc. (HTBX:NASDAQ), 142.42%
- Novan, Inc. (NOVN:NASDAQ), 112.51%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 100%
- BioPharmX Corporation (BPMX:NYSEMKT), 78.38%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 69.65%
- Daxor Corporation (DXR:NYSEMKT), 65.7%
- Forty Seven, Inc. (FTSV:NASDAQ), 61.91%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 55.83%
- NuCana plc (NCNA:NASDAQ), 45.74%
- InflaRx N.V. (IFRX:NASDAQ), 43.4%